Supply of palivizumab medicinal product

Summary

The tender concerns the supply of a palivizumab-containing medicinal product for the prevention of severe RSV-related lower respiratory tract disease in high-risk children. The medicine is supplied in 0.5 ml vials containing 50 mg palivizumab; the total quantity offered is up to 1,200 vials. The estimated framework maximum amount is EUR 369,948.60 and the estimated total contract amount is EUR 352,332. The contract duration is 24 months; bids are submitted electronically; delivery is to Banská Bystrica, Slovakia; the procurement is open and SMEs are considered suitable; the tender concerns palivizumab medicine.